3,4-DICHLOROPHENYL ISOTHIOCYANATE | CAS:6590-94-9

We serve 3,4-DICHLOROPHENYL ISOTHIOCYANATE CAS:6590-94-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
3,4-DICHLOROPHENYL ISOTHIOCYANATE

Chemical Name:3,4-DICHLOROPHENYL ISOTHIOCYANATE
CAS.NO:6590-94-9
Synonyms:3,4-DICHLOROPHENYL ISOTHIOCYANATE
1,2-dichloro-4-isothiocyanatobenzene
 
Physical and Chemical Properties:
Density 1.422 g/mL at 25 °C(lit.)
Boiling Point 134-136 °C7 mm Hg(lit.)
Molecular Formula C7H3Cl2NS
Molecular Weight 204.07600
Flash Point >230 °F
 
Specification:
Appearance:Orange-yellow transparent liquid
Assay:≥99.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate



Contact us for information like 3,4-DICHLOROPHENYL ISOTHIOCYANATE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1,2-dichloro-4-isothiocyanatobenzene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,2-dichloro-4-isothiocyanatobenzene Use and application,1,2-dichloro-4-isothiocyanatobenzene technical grade,usp/ep/jp grade.


Related News: Although bird flu poses more of a danger to poultry than humans — it is not easily transmissible among people — the World Health Organization has called on countries to be on guard because the virus can mutate into a transmissible form and has the potential to cause a pandemic.4-[5-(4-Pentyloxyphenyl)isoxazol-3-yl]benzoic acid manufacturer Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for cancer and immune disorders.2,4-Dibromopyridine supplier Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for cancer and immune disorders.2-(Trifluoromethyl)benzoyl chloride vendor Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for cancer and immune disorders.This is called API. A small amount of the active ingredient has an effect, so only a tiny part of the active ingredient is contained in medicine.